{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:41:35Z","timestamp":1760589695848,"version":"build-2065373602"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cavernous sinus hemangiomas (CSH) are considered benign vascular skull base tumors. Surgical therapy is the primary treatment due to the neurological deficits resulting from the compressive effects of the mass. However, patients with tumors located in critical areas or those with large tumor volume, surgical resection may be difficult or even unfeasible.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Description<\/jats:title><jats:p>We report the case of a female patient with a 10-year history of progressive right orbital swelling and visual impairment. Imaging revealed a giant CSH with a tumor volume of 144 cm\u00b3. The patient underwent limited debulking surgery one year prior, with substantial residual tumor burden and persistent right facial swelling, particularly in the periorbital region.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>The patient subsequently received hyperarc-based hypofractionated radiotherapy, delivered at a dose of 30 Gy in 10 fractions (3 Gy per fraction), followed by clinicoradiologic assessments at 6-month intervals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcome<\/jats:title><jats:p>Radiologic evaluation at 6 months post-radiotherapy demonstrated a 69% reduction in tumor volume. Significant improvement in facial swelling and restoration of facial symmetry were observed. However, right-sided ptosis and vision loss persisted, likely due to irreversible optic nerve damage. A transient alopecia noted at 2 months post-treatment resolved completely by the 6-month follow-up. No acute or late radiation-related toxicities were reported during a 13-month follow-up period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The treatment achieved marked tumor regression and clinical improvement with an excellent safety profile. Hypofractionated radiotherapy may be serve as an alternative effective approach in these unresectable lesions with a favorable safety profile.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1557291","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:16:40Z","timestamp":1760588200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Therapeutic effect of hypofractionated radiotherapy using HyperArc for giant cavernous sinus hemangiomas"],"prefix":"10.3389","volume":"15","author":[{"given":"Mengqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baodong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.349630","article-title":"Surgical management of a superior orbital fissure cavernous hemangioma","volume":"70","author":"Padilla-Lichtenberger","year":"2022","journal-title":"Neurol India"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10143-018-0975-8","article-title":"Safety and efficacy of single-fraction gamma knife radiosurgery for benign confined cavernous sinus tumors: our experience and literature review","volume":"43","author":"Tripathi","year":"2020","journal-title":"Neurosurgical review"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.317234","article-title":"Primary hypofractionated gamma knife radiosurgery for giant cavernous sinus hemangiomas","volume":"69","author":"Tripathi","year":"2021","journal-title":"Neurol India"},{"key":"B4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.21037\/acr-24-88","article-title":"HyperArc radiotherapy for recurrent synovial sarcoma of infratemporal fossa: a rare case report and review of the literature","volume":"8","author":"Li","year":"2024","journal-title":"AME Case Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.meddos.2019.07.004","article-title":"Effect of collimator angle on HyperArc stereotactic radiosurgery planning for single and multiple brain metastases","volume":"45","author":"Ohira","year":"2020","journal-title":"Med dosimetry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.11.014","article-title":"Linac-based radiosurgery for multiple brain metastases: Comparison between two mono-isocenter techniques with multiple non-coplanar arcs","volume":"132","author":"Ruggieri","year":"2019","journal-title":"Radiotherapy Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00483","article-title":"Multi-institutional dosimetric evaluation of modern day stereotactic radiosurgery (SRS) treatment options for multiple brain metastases","volume":"9","author":"Vergalasova","year":"2019","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1055\/s-0037-1602790","article-title":"Multimodality management of cavernous sinus hemangiomas-an institutional experience","volume":"78","author":"Srinivas","year":"2017","journal-title":"J neurological Surg Part B Skull base"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2012.01.050","article-title":"Surgical management of large and giant cavernous sinus hemangiomas","volume":"20","author":"Yin","year":"2013","journal-title":"J Clin Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctro.2018.11.004","article-title":"Radiation-induced vascular malformations in the brain, mimicking tumor in MRI-based treatment response assessment maps (TRAMs)","volume":"15","author":"Guez","year":"2019","journal-title":"Clin Trans Radiat Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1065346","article-title":"Low-dose gamma knife radiosurgery for cavernous sinus hemangioma: report of 3 cases and literature review","volume":"51","author":"Ivanov","year":"2008","journal-title":"Minimally invasive neurosurgery: MIN"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1227\/01.Neu.0000378026.23116.E6","article-title":"Gamma knife surgery for cavernous hemangiomas in the cavernous sinus","volume":"67","author":"Chou","year":"2010","journal-title":"Neurosurgery"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.07.090","article-title":"Safety and efficacy of primary multisession dose fractionated gamma knife radiosurgery for jugular paragangliomas","volume":"131","author":"Tripathi","year":"2019","journal-title":"World neurosurgery"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717x-5-77","article-title":"Single fraction radiosurgery using Rapid Arc for treatment of intracranial targets","volume":"5","author":"Wolff","year":"2010","journal-title":"Radiat Oncol (London England)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13185497","article-title":"Dosimetric comparison between the hyperArc and conventional VMAT in cervical spine stereotactic radiosurgery","volume":"13","author":"Park","year":"2024","journal-title":"J cilinc medcine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-022-02150-y","article-title":"Dosimetric quality of HyperArc in boost radiotherapy for single glioblastoma: comparison with CyberKnife and manual VMAT","volume":"18","author":"Pan","year":"2023","journal-title":"Radiat Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2024-021843","article-title":"Gene therapy for intracranial aneurysms: systemic review","volume":"17","author":"McAvoy","year":"2024","journal-title":"J neurointerv Surg"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1557291\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:16:43Z","timestamp":1760588203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1557291\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":17,"alternative-id":["10.3389\/fonc.2025.1557291"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1557291","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"article-number":"1557291"}}